"Significant efficacy of cysteamine for the treatment of epidermal melasma"

BJD Cysteamine Cream_2015.png

by Mansouri P. et al. 2015. British Journal of Dermatology

 

Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial

Mansouri P. et al.

British Journal of Dermatology, 2015

Melasma is a difficult-to-treat hyperpigmentary disorder. While cysteamine is a known potent depigmenting agent, the study conducted by Professor Parvin Mansouri of the Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Iran, has demonstrated significant efficacy of Cysteamine Cream® in the treatment of patients with epidermal melasma.